Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,074 | -27,816 | -5,893 | -2,606 | -5,569 |
| Depreciation Amortization | 235 | 92 | 178 | 95 | 7 |
| Other Working Capital | -2,360 | -1,181 | 340 | 699 | -540 |
| Other Operating Activity | 18,107 | 24,264 | -206 | -458 | -2,378 |
| Operating Cash Flow | $-12,092 | $-4,641 | $-5,581 | $-2,270 | $-8,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -156 | N/A | -11 | -8 | -16 |
| Net Acquisitions | 69 | 69 | 0 | N/A | 0 |
| Other Investing Activity | -49,508 | 39 | -438 | -5,470 | 2,060 |
| Investing Cash Flow | $-49,595 | $108 | $-449 | $-5,478 | $2,044 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 68,488 | 63,157 | 5,233 | 5,329 | 7,788 |
| Financing Cash Flow | $68,488 | $63,157 | $5,233 | $5,329 | $7,788 |
| Exchange Rate Effect | 61 | -14 | 19 | 13 | -136 |
| Beginning Cash Position | 4,385 | 4,385 | 5,163 | 5,163 | 3,947 |
| End Cash Position | 11,247 | 62,995 | 4,385 | 2,757 | 5,163 |
| Net Cash Flow | $6,862 | $58,610 | $-778 | $-2,406 | $1,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,092 | -4,641 | -5,581 | -2,270 | -8,480 |
| Free Cash Flow | -12,092 | -4,641 | -5,581 | -2,270 | -8,480 |